419 related articles for article (PubMed ID: 28522607)
1. NleB/SseK effectors from
El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
[TBL] [Abstract][Full Text] [Related]
2. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
[TBL] [Abstract][Full Text] [Related]
3. Type III Secretion Effectors with Arginine N-Glycosyltransferase Activity.
Araujo-Garrido JL; Bernal-Bayard J; Ramos-Morales F
Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32131463
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL
Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593
[TBL] [Abstract][Full Text] [Related]
5. Catalytic DxD motif caged in Asx-turn and Met-aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors.
Koh E; Kim U; Cho HS
Sci Rep; 2022 Nov; 12(1):19288. PubMed ID: 36369343
[TBL] [Abstract][Full Text] [Related]
6. A type III effector antagonizes death receptor signalling during bacterial gut infection.
Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
[TBL] [Abstract][Full Text] [Related]
7. NleB/SseK-catalyzed arginine-glycosylation and enteropathogen virulence are finely tuned by a single variable position contiguous to the catalytic machinery.
García-García A; Hicks T; El Qaidi S; Zhu C; Hardwidge PR; Angulo J; Hurtado-Guerrero R
Chem Sci; 2021 Sep; 12(36):12181-12191. PubMed ID: 34667584
[TBL] [Abstract][Full Text] [Related]
8. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation.
Gao X; Wang X; Pham TH; Feuerbacher LA; Lubos ML; Huang M; Olsen R; Mushegian A; Slawson C; Hardwidge PR
Cell Host Microbe; 2013 Jan; 13(1):87-99. PubMed ID: 23332158
[TBL] [Abstract][Full Text] [Related]
9. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.
Giogha C; Scott NE; Wong Fok Lung T; Pollock GL; Harper M; Goddard-Borger ED; Pearson JS; Hartland EL
PLoS Pathog; 2021 Jun; 17(6):e1009658. PubMed ID: 34133469
[TBL] [Abstract][Full Text] [Related]
10. Arg-GlcNAcylation on TRADD by NleB and SseK1 Is Crucial for Bacterial Pathogenesis.
Xue J; Hu S; Huang Y; Zhang Q; Yi X; Pan X; Li S
Front Cell Dev Biol; 2020; 8():641. PubMed ID: 32766249
[TBL] [Abstract][Full Text] [Related]
11. Auto Arginine-GlcNAcylation Is Crucial for Bacterial Pathogens in Regulating Host Cell Death.
Xue J; Pan X; Peng T; Duan M; Du L; Zhuang X; Cai X; Yi X; Fu Y; Li S
Front Cell Infect Microbiol; 2020; 10():197. PubMed ID: 32432056
[TBL] [Abstract][Full Text] [Related]
12. An intra-bacterial activity for a T3SS effector.
El Qaidi S; Scott NE; Hays MP; Geisbrecht BV; Watkins S; Hardwidge PR
Sci Rep; 2020 Jan; 10(1):1073. PubMed ID: 31974499
[TBL] [Abstract][Full Text] [Related]
13. SseK1 and SseK3 Type III Secretion System Effectors Inhibit NF-κB Signaling and Necroptotic Cell Death in Salmonella-Infected Macrophages.
Günster RA; Matthews SA; Holden DW; Thurston TLM
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069818
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors.
El Qaidi S; Zhu C; McDonald P; Roy A; Maity PK; Rane D; Perera C; Hardwidge PR
Front Cell Infect Microbiol; 2018; 8():435. PubMed ID: 30619781
[TBL] [Abstract][Full Text] [Related]
15. Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.
Pollock GL; Oates CVL; Giogha C; Wong Fok Lung T; Ong SY; Pearson JS; Hartland EL
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138023
[TBL] [Abstract][Full Text] [Related]
16. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains.
Li S; Zhang L; Yao Q; Li L; Dong N; Rong J; Gao W; Ding X; Sun L; Chen X; Chen S; Shao F
Nature; 2013 Sep; 501(7466):242-6. PubMed ID: 23955153
[TBL] [Abstract][Full Text] [Related]
17. Citrobacter rodentium NleB Protein Inhibits Tumor Necrosis Factor (TNF) Receptor-associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production.
Gao X; Pham TH; Feuerbacher LA; Chen K; Hays MP; Singh G; Rueter C; Hurtado-Guerrero R; Hardwidge PR
J Biol Chem; 2016 Aug; 291(35):18232-8. PubMed ID: 27387501
[TBL] [Abstract][Full Text] [Related]
18. YM155 Inhibits NleB and SseK Arginine Glycosyltransferase Activity.
Zhu C; El Qaidi S; McDonald P; Roy A; Hardwidge PR
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33672424
[TBL] [Abstract][Full Text] [Related]
19. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
El Qaidi S; Wu M; Zhu C; Hardwidge PR
Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
[TBL] [Abstract][Full Text] [Related]
20. Type Three Secretion System in Attaching and Effacing Pathogens.
Gaytán MO; Martínez-Santos VI; Soto E; González-Pedrajo B
Front Cell Infect Microbiol; 2016; 6():129. PubMed ID: 27818950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
